+

WO2002036608A3 - Haplotypes du gene cyp1a2 - Google Patents

Haplotypes du gene cyp1a2 Download PDF

Info

Publication number
WO2002036608A3
WO2002036608A3 PCT/US2001/042637 US0142637W WO0236608A3 WO 2002036608 A3 WO2002036608 A3 WO 2002036608A3 US 0142637 W US0142637 W US 0142637W WO 0236608 A3 WO0236608 A3 WO 0236608A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
cyp1a2
gene
disclosed
cyp1a2 gene
Prior art date
Application number
PCT/US2001/042637
Other languages
English (en)
Other versions
WO2002036608A2 (fr
Inventor
Steven C Bentivegna
Amir Kazemi
Beena Koshy
Katie E Parks
Eileen Rounds
Elizabeth Ann Sausker
Original Assignee
Genaissance Pharmaceuticals
Steven C Bentivegna
Amir Kazemi
Beena Koshy
Katie E Parks
Eileen Rounds
Elizabeth Ann Sausker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Steven C Bentivegna, Amir Kazemi, Beena Koshy, Katie E Parks, Eileen Rounds, Elizabeth Ann Sausker filed Critical Genaissance Pharmaceuticals
Priority to AU2002230402A priority Critical patent/AU2002230402A1/en
Publication of WO2002036608A2 publication Critical patent/WO2002036608A2/fr
Publication of WO2002036608A3 publication Critical patent/WO2002036608A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des variantes génétiques du gène CYP1A2 (Cytochrome P450, Sous-famille I (inductible par composé aromatique), Polypeptide 2). L'invention concerne également divers génotypes, haplotypes et paires d'haplotypes du gène CYP1A2 existant dans la population générale des Etats-Unis. L'invention concerne en outre des compositions et des méthodes d'haplotypage et/ou de génotypage du gène CYP1A2 chez un individu. L'invention concerne enfin des polynucléotides définis par les haplotypes selon l'invention.
PCT/US2001/042637 2000-10-11 2001-10-11 Haplotypes du gene cyp1a2 WO2002036608A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002230402A AU2002230402A1 (en) 2000-10-11 2001-10-11 Haplotypes of the cyp1a2 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23974000P 2000-10-11 2000-10-11
US60/239,740 2000-10-11

Publications (2)

Publication Number Publication Date
WO2002036608A2 WO2002036608A2 (fr) 2002-05-10
WO2002036608A3 true WO2002036608A3 (fr) 2003-12-11

Family

ID=22903513

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/042637 WO2002036608A2 (fr) 2000-10-11 2001-10-11 Haplotypes du gene cyp1a2

Country Status (2)

Country Link
AU (1) AU2002230402A1 (fr)
WO (1) WO2002036608A2 (fr)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] CHEVALIER ET AL.: "Mutation and polymorphism report", XP002959386, Database accession no. (AH002667) *
HUMAN MUTATION. REPORT #233 ONLINE, April 2001 (2001-04-01) *
IKEYA ET AL.: "Human CYP1A2: Sequence, gene structure, comparison with the mouse and rat orthologous gene and differences in liver 1A2 mRNA expression", MOL. ENDOCRINOLOGY, vol. 3, no. 9, 1989, pages 1399 - 1408, XP002959388 *
RALLAN ET AL.: "Identification of novel polymorphisms within the cytochrome P450 1A2 (CYP1A2) gene", J. MEDICAL GENETICS, vol. 36, no. 591, SUPPL. 1, September 1999 (1999-09-01), pages S91, XP002959387 *

Also Published As

Publication number Publication date
AU2002230402A1 (en) 2002-05-15
WO2002036608A2 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
WO2002038589A3 (fr) Haplotypes du gene cyp2d6
WO2002026768A3 (fr) Haplotypes du gene por
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2002030951A3 (fr) Haplotypes du gene cyp1b1
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2002046209A3 (fr) Haplotypes du gene cyp3a5
WO2002036608A3 (fr) Haplotypes du gene cyp1a2
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2002062820A3 (fr) Haplotypes du gene cyp27b1
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2001079224A3 (fr) Haplotypes du gene cyp8b1
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2002032930A3 (fr) Haplotypes du gene scya21
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002053579A3 (fr) Haplotypes du gene fmo2
WO2002030952A3 (fr) Haplotypes du gene cyp27a1
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2002040503A3 (fr) Haplotypes du gène plau
WO2002016400A3 (fr) Haplotypes du gene scya26
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2002055534A3 (fr) Haplotypes du gene f2rli
WO2002063044A3 (fr) Haplotypes du gene il15

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载